Wynzora
Intended to target inflammatory skin lesions to alleviate psoriasis symptoms.
- Category
- Skin Care
- Active ingredients
- Betamethasone · Calcipotriol
- Supply
- Pharmacy
- Route
- Cutaneous use
- Form
- Cream
- Strengths
- 0.05/0.005%
Wynzora details
- Condition
- Plaque Psoriasis
- Therapeutic class
- Corticosteroid; Vitamin D analogue
- Pharmacological class
- Glucocorticoids; Vitamin D3 derivative
- Minor side effects
- pruritus; skin irritation
- Moderate side effects
- folliculitis; skin atrophy; pigmentary changes
- Dosage forms
- Cream
- Administration route
- Cutaneous use
- Patient summary
- intended to target inflammatory skin lesions to alleviate psoriasis symptoms.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- LEO Pharma
- Onset Time
- 1–2 weeks
- Duration
- up to 8 weeks
- Storage instructions
- Store below 25°C.
- Age restrictions
- Not for children under 18 years.
Contraindications
calcium metabolism disturbance; viral skin infections; tuberculosis of the skin; hypersensitivity to components
Precautions and warnings
avoid application on the face; limit total weekly dosage; avoid excessive exposure to sunlight
Serious side effects
hypercalcaemia, requires immediate medical attention; cushing's syndrome, requires immediate medical attention
Mechanism of action
Combines a potent corticosteroid for anti-inflammatory effects and a vitamin D analogue to regulate skin cell growth and reduce hyperproliferation.
Pregnancy and breastfeeding
Pregnancy: Use with caution only if benefits outweigh risks. Breastfeeding: Avoid application to the breasts.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Wynzora
Wynzora contains the fixed combination of Betamethasone and Calcipotriol, indicated for the management of plaque psoriasis. Produced by LEO Pharma, the preparation is supplied in a tube with a concentration of 0.05/0.005%. It provides users a targeted formulation for skin conditions requiring this specific topical approach in a standard, convenient form.
Buying Wynzora online
Wynzora is registered across 14 markets including the Philippines, Indonesia and Taiwan, with availability also in South Korea, Japan and the UAE. One of the most ordered treatments across the region, it is frequently sourced online by expats and others living far from a well-stocked pharmacy. Accessing this product through digital channels simplifies the process for those who require consistent supply in areas where local availability may fluctuate.